From Name

From Email

To Name

To Email

Message

Pembrolizumab plus chemotherapy extends PFS in breast cancer subset

from HemOnc Today

Pembrolizumab plus chemotherapy extends PFS in breast cancer subset HemOnc Today The addition of pembrolizumab to various chemotherapy partners improved PFS among certain patients with inoperable or metastatic triple-negative breast cancer, according to study results presented at ASCO20 Virtual Scientific Program. READ MORE

more